Review on long‐term non‐renal complications of childhood nephrotic syndrome

Nephrotic syndrome (NS) is the most common glomerular childhood disease. A body of literature has described the long‐term renal prognosis of childhood‐onset idiopathic NS. However, the nonrenal outcomes have not been studied as much.

[1]  M. Born,et al.  The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study , 2019, Clinical and Experimental Nephrology.

[2]  A. Bagga,et al.  Management of steroid-resistant nephrotic syndrome in children and adolescents. , 2018, The Lancet. Child & adolescent health.

[3]  E. Valavi,et al.  Effect of prednisolone on linear growth in children with nephrotic syndrome , 2018, Jornal de pediatria.

[4]  R. Parekh,et al.  Idiopathic nephrotic syndrome in children , 2018, The Lancet.

[5]  S. Krishnamurthy,et al.  Assessment of quality of life in children with nephrotic syndrome at a teaching hospital in South India. , 2017, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[6]  K. Devpura,et al.  Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome. , 2017, Journal of clinical and diagnostic research : JCDR.

[7]  H. Siebner,et al.  Children and adolescents previously treated with glucocorticoids display lower verbal intellectual abilities , 2015, Acta paediatrica.

[8]  B. Reeve,et al.  The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study , 2015, Pediatric Nephrology.

[9]  F. Gök,et al.  Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience. , 2015, Turk pediatri arsivi.

[10]  K. Nakanishi,et al.  Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial , 2015, Pediatric Nephrology.

[11]  K. Nakanishi,et al.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy , 2015, Clinical and Experimental Nephrology.

[12]  S. Lakshminarayanan,et al.  Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case–control study , 2015, Clinical and Experimental Nephrology.

[13]  E. Girardin,et al.  Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome , 2015, European Journal of Pediatrics.

[14]  A. Jakubowska,et al.  Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood. , 2014, Clinical nephrology.

[15]  A. Iyengar,et al.  Ocular Complications in Children with Nephrotic Syndrome on Long Term Oral Steroids , 2014, The Indian Journal of Pediatrics.

[16]  B. C. Kwan,et al.  Long-term outcome of biopsy-proven minimal-change nephrotic syndrome in Chinese children , 2013 .

[17]  T. Ulinski,et al.  Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? , 2013, Pediatric Nephrology.

[18]  D. Hébert,et al.  The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome , 2013, BMC Nephrology.

[19]  A. Libório,et al.  Proteinuria Is Associated with Quality of Life and Depression in Adults with Primary Glomerulopathy and Preserved Renal Function , 2012, PloS one.

[20]  A. Merrikhi,et al.  Steroid Dependent and Independent Ocular Findings in Iranian Children with Nephrotic Syndrome , 2011, International journal of preventive medicine.

[21]  T. Greene,et al.  Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. , 2011, Kidney international.

[22]  Lee Ryan N. Olonan,et al.  Steroid-induced cataract and glaucoma in pediatric patients with nephrotic syndrome , 2009 .

[23]  V. Koch,et al.  Final height of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome , 2009, Pediatric Nephrology.

[24]  W. Oyen,et al.  Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[25]  A. Obuchowicz,et al.  Evaluation of certain constituents of antioxidant defense in youth treated in the past for steroid-sensitive idiopathic nephrotic syndrome , 2009, Pediatric Nephrology.

[26]  A. Obuchowicz,et al.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome , 2008, Pediatric Nephrology.

[27]  J. Karlsson,et al.  Effects of dexamethasone on human lens epithelial cells in culture , 2008, Molecular vision.

[28]  Vanita Gupta,et al.  Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells. , 2007, Investigative ophthalmology & visual science.

[29]  J. Shults,et al.  Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome , 2006, Pediatric Nephrology.

[30]  Y. Hayasaka,et al.  Ocular Findings in Japanese Children with Nephrotic Syndrome Receiving Prolonged Corticosteroid Therapy , 2006, Ophthalmologica.

[31]  D. Gipson,et al.  Differential risk of remission and ESRD in childhood FSGS , 2006, Pediatric Nephrology.

[32]  J. Hegarty,et al.  Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. , 2005, Kidney international.

[33]  Raj K Sharma,et al.  Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  M. Kemper,et al.  Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. , 2005, The Journal of pediatrics.

[35]  M. Kemper,et al.  Health-related quality of life and psychosocial adjustment in steroid-sensitive nephrotic syndrome. , 2004, The Journal of pediatrics.

[36]  J. Wetzels.  Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? , 2004, The Netherlands journal of medicine.

[37]  J. Shults,et al.  Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. , 2004, The New England journal of medicine.

[38]  E. Levy,et al.  Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. , 2003, Clinical biochemistry.

[39]  G. Rizzoni,et al.  Long-term linear growth of children with severe steroid-responsive nephrotic syndrome , 2003, Pediatric Nephrology.

[40]  V. Koch,et al.  Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients , 2003, Pediatric Nephrology.

[41]  Paul Landais,et al.  Steroid-sensitive nephrotic syndrome: from childhood to adulthood. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  S. Ahmed,et al.  The impact of corticosteroids on growth and bone health , 2002, Archives of disease in childhood.

[43]  W. Wong,et al.  Ocular complications of paediatric patients with nephrotic syndrome , 2001, Clinical & experimental ophthalmology.

[44]  J. Ehrich,et al.  A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children , 2001, Pediatric Nephrology.

[45]  K. Schärer,et al.  Body growth of children with steroid-resistant nephrotic syndrome , 1999, Pediatric Nephrology.

[46]  K. Yoshioka,et al.  Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  G. Mclauchlan,et al.  Epidemiology of fractures in 15 000 adults: The influence of age and gender , 1998 .

[48]  J. Tobin,et al.  Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. , 1997, Journal of the American Society of Nephrology : JASN.

[49]  T. Barratt,et al.  Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood , 1994, Pediatric Nephrology.

[50]  R. Hiatt,et al.  The increased risk of coronary heart disease associated with nephrotic syndrome. , 1993, Kidney international.

[51]  N. Yoshikawa,et al.  Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome , 1993, Pediatric Nephrology.

[52]  A. Elzouki,et al.  Long-term, Small Dose Prednisone Therapy in Frequently Relapsing Nephrotic Syndrome of Childhood , 1988, Clinical pediatrics.

[53]  R. Merritt,et al.  Corticosteroid Therapy-induced Obesity in Children , 1986, Clinical pediatrics.

[54]  T. Barratt,et al.  GONADAL FUNCTION IN BOYS WITH STEROID-RESPONSIVE NEPHROTIC SYNDROME TREATED WITH CYCLOPHOSPHAMIDE FOR SHORT PERIODS , 1981, The Lancet.

[55]  M. Brandis,et al.  Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood , 1981, European Journal of Pediatrics.

[56]  S. Agrawal,et al.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment , 2018, Nature Reviews Nephrology.

[57]  S. Ito,et al.  Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[58]  B. Frenkel,et al.  Glucocorticoid-Induced Osteoporosis. , 2015, Advances in experimental medicine and biology.

[59]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .

[60]  H. Coovadia,et al.  Effects of repeated courses of daily steroids and of persistent proteinuria on linear growth in children with nephrotic syndrome , 2004, Pediatric Nephrology.

[61]  Anup Singh,et al.  One-center experience with cyclosporine in refractory nephrotic syndrome in children , 1999, Pediatric Nephrology.

[62]  R. Bucala,et al.  Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: in vitro and in vivo studies. , 1985, Experimental eye research.

[63]  S. R. Meadow,et al.  Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. , 1982, Archives of disease in childhood.